Attribution of colorectal cancer symptoms to medications for pre-existing chronic conditions: a secondary analysis of a vignette study in England
Authors:
Open Access
- 20 February 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 47 (2) , 144-148
Abstract
Objective: To investigate the likelihood of attributing colorectal cancer (CRC) symptoms to medications for chronic conditions. Methods: The online vignette survey included 1287 participants aged ≥50 years, with quota sampling to recruit sufficient participants with type 2 diabetes. Participants self-reported chronic conditions and answered questions on symptom attribution and help-seeking, after reading vignettes describing new-onset rectal bleeding or change in bowel habit. Using multivariable logistic regression, we analyzed the association between specific conditions and attributing new-onset CRC symptoms to medications, controlling for demographics. Results: Among participants, 25% reported type 2 diabetes, 31% being overweight, 25% hypertension and 22% arthritis. Participants with diabetes, versus those without, had a higher likelihood of attributing change in bowel habit to medications [7% vs 3%; adjusted Odds Ratio (aOR) 2.55, Confidence Interval (95% CI) 1.30–5.00]. This was also the case for participants reporting being overweight (7% vs 2%; aOR 2.36, 95% CI 1.25–4.44), arthritis (8% vs 3%; aOR 2.27, 95% CI 1.19–4.35), but not for hypertension. No significant association was found regarding attribution of rectal bleeding to medications. Conclusions: Patients with common chronic conditions have a higher likelihood of attributing change in bowel habit to medications. Tailored information is needed for these patients, encouraging them to discuss any new symptom with their doctor.Keywords
Funding Information
- National Institute for Health and Care Research
- Screening and Early Diagnosis (NIHR206132)
- NIHR Programme Grants for Applied Research (NIHR201070)
- Department of Health and Social Care
This publication has 14 references indexed in Scilit:
- Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6Diabetes Care, 2023
- The Role of Type 2 Diabetes in Patient Symptom Attribution, Help-Seeking, and Attitudes to Investigations for Colorectal Cancer Symptoms: An Online Vignette StudyCancers, 2023
- Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system databaseFrontiers in Endocrinology, 2022
- Factors influencing symptom appraisal and help-seeking of older adults with possible cancer: a mixed-methods systematic reviewBritish Journal of General Practice, 2022
- An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal CancerGastroenterology, 2021
- Effect of pre-existing conditions on bladder cancer stage at diagnosis: a cohort study using electronic primary care records in the UKBritish Journal of General Practice, 2020
- Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanismsNature Reviews Clinical Oncology, 2019
- Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysisPLOS ONE, 2018
- Coping With Prediagnosis Symptoms of Colorectal CancerCancer Nursing, 2017
- Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic reviewBritish Journal of Cancer, 2007